Healthcare

This report will provide:

• An overview of breast cancer diagnostic and drug technologies, including immunohistochemical (IHC) testing, fluorescent in situ hybridization techniques (FISH), genomic analysis, and quantitative immunofluorescence
• Analyses of global market trends, with data from 2010, estimates for 2011, and projections of compound annual growth rates (CAGRs) through 2016
• A breakdown of diagnosis technologies, including noninvasive exam, mammography and fine needle aspiration and cytology (FNAC)
• Discussion of competition in the global mammography equipment market and the roles of MRI and ultrasound
• Evaluation of the use of biomarkers in drug development and clinical trials
• Delineation of breast cancer incidence in countries around the world
• Comprehensive company profiles of key players.

Target Date: May 2012 Report ID: HLC106A Report Author: Usha Nagavarapu Price: $4,850.00

• The global medical device coating market reached $4.8 billion in 2010 and $5.4 billion in 2011. The market is expected to grow from $5.7 billion in 2012 to nearly $8 billion in 2017, a five-year compound annual growth rate (CAGR) of 6.7%.
• The United States market for medical device coatings reached $2.7 billion in 2011, is expected to reach nearly $3 billion in 2012, and should total nearly $4.4 billion by 2017, a five-year CAGR of 8.1%.
• The European Union market for medical device coatings reached $1.3 billion in 2011, is expected to reach $1.4 billion in 2012, and should surpass $2 billion in 2017, a five-year CAGR of 7.0%.

Target Date: May 2012 Report ID: HLC049C Report Author: Jim Wilson Price: $4,850.00

This report will contain:

• Examination of portable medical electronic products, specifically medical diagnostic equipment and imaging systems, drug delivery devices, interventional medical electronics, first-aid equipment, and body function testers
• Analysis of market trends, with data for 2008 and 2009, estimates for 2010, and projections of compound annual growth rates (CAGRs) through 2015
• An outline of current technical issues, detailing new technological developments and providing examples of significant patents that have been recently issued or for which applications have been submitted
• A list of the leading suppliers of portable medical electronic products and technology developers, with descriptions of their products
• Detailed company profiles of the top industry players and relative market shares.

Target Date: June 2012 Report ID: HLC084A Report Author: Margareth Gagliardi Price: $4,850.00

This report will provide:

• An overview of the global market for continuous glucose monitoring (CGM) with product-based segmentation related to implanted and minimally- and non-invasive methods
• Analyses of global market trends, with historical data from 2009 and 2010, estimates for 2011, and projections of compound annual growth rates (CAGRs) through 2016
• A breakdown of the diabetes care devices market by geography (U.S., Europe, Asia, and rest of the world) and product type (insulin pumps, self-monitoring of blood glucose, continuous glucose monitoring, near IR detection, ultrasound, dielectric spectroscopy)
• Market estimates and forecasts of CGM by application areas, type of diabetes, by age, and by race
• Competitive intelligence, including new product launches, M&A and joint ventures, and key market strategies
• Comprehensive company profiles
• Lists of patents in the U.S., Europe, and Japan.

Target Date: June 2012 Report ID: HLC102A Report Author: Varsha Bhat Price: $4,850.00

This report will provide:

• An overview of heart failure treatments, including the following drug classes: angiotensin-converting enzyme (ACE) inhibitors, angiotensin II receptor blockers (ARBs), aldosterone antagonists, beta blockers, digoxin, diuretics, hydralazine and long-acting nitrates, and other pharmaceuticals such as anticoagulants and statins; as well as surgical interventions: heart valve repair or replacement, implantable cardioverter-defibrillators (ICDs), cardiac resynchronization therapy (CRT), heart pumps (left ventricular assist devices, or LVADs) and artificial hearts, and heart transplants
• Discussion of diagnostic methods, including blood tests, chest X-rays, electrocardiogram, echocardiogram, pulmonary function tests, stress tests, CT and MRI, and angiograms
• Analysis of global market trends, with data from 2009, estimates for 2010, and projections of compound annual growth rates (CAGRs) through 2015
• Evaluation of the impact of heart failure on healthcare systems around the world
• Examinations of emerging technologies, including drug therapies, new device options, artificial hearts, and stem cell technologies
• Comprehensive company profiles.

Target Date: July 2012 Report ID: HLC088A Report Author: Patricia DeGrandchamp Price: $4,850.00

This report will provide:

• An overview of the markets for therapeutic drugs and diagnostics for dermatological disorders
• Analyses of global market trends, with data from 2011, estimates for 2012, and projections of compound annual growth rates (CAGRs) through 2017
• An examination of the alternative and complementary modes of treatment and their important role apart from prescription drug treatment in dermatological therapy; recent developments in chemical peels, cryotherapy, ultraviolet, and laser therapy are studied
• Identification of industry participants and noncommercial dermatological organizations
• Discussion of significant, recent international market developments reported in various publications
• Comprehensive company profiles of major players in the industry.

Target Date: July 2012 Report ID: HLC057B Report Author: Valerie Kellogg Price: $4,850.00

This report will provide:

• An overview of the global markets for computed tomography (CT) scanners, which account for approximately 20% of the total imaging modalities market share
• Analyses of global market trends, with data from 2011, estimates for 2012, and projections of compound annual growth rates (CAGRs) through 2017
• Coverage of market segments that include high-slice CT systems, mid-slice CT systems, and low-slice CT systems; and CT systems by clinical applications, such as oncology, cardiovascular, neurology, and bone densitometry
• Examination of the competitive landscape, leading pipeline products, pricing, and technology offerings
• Identification of the industry's dominating players, namely General Electric, Siemens, Toshiba, and Philips
• CT breakthroughs in cardiac, cancer detection, cancer diagnosis, neurologic diagnosis, and new clinical applications
• Regulatory status of CT scanners in the U.S., Japan, the European Union, Asia, and the rest of the world
• Comprehensive company profiles.

Target Date: August 2012 Report ID: HLC024A Report Author: Smruti Munshi Price: $4,850.00